Owners, management and financials
CVR: 34708215
DKK -475,262
Gross profit
Net result: DKK -594,882
Ranoda Holding ApS (100%)
CVR · view owners
Birgit Ter-Borch Gram Lilienfeldt Schjoldager
CVR · view management
Active
Founded 21 September 2012
CVR · view overview
1 employee
CVR · 2026
Owner registered: Ranoda Holding ApS
CVR · 16/02/2016
View the full event history
STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.
Selskabets formål er at eje og udvikle lægemidler til anvendelse mod sygdomstilstande, herunder patenter for aktiveret blodkoagulationsfaktor VII (FVIIa) eller et biologisk derivat heraf til lokal behandling af livstruende blødninger i forbindelse med fødsel med tilgængelighed i ikke-ressourcestærke lande, og anden hermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -475K | -595K | 1.3M | -3.6M | 1 | |
| 202401/01/2024 – 31/12/2024 | -336K | -487K | 989K | -3M | 1 | |
| 202301/01/2023 – 31/12/2023 | -256K | -803K | 388K | -2.5M | 1 | |
| 202201/01/2022 – 31/12/2022 | -162K | -786K | 530K | -1.7M | 1 | |
| 202101/01/2021 – 31/12/2021 | -102K | -539K | 245K | -895K | 1 | |
| 202001/01/2020 – 31/12/2020 | -101K | -79K | 19K | -356K | - | |
| 201901/01/2019 – 31/12/2019 | -71K | -58K | 68K | -277K | - | |
| 201801/01/2018 – 31/12/2018 | -70K | -113K | 2K | -219K | 0 | |
| 201701/01/2017 – 31/12/2017 | -45K | -78K | 28K | -107K | 0 | |
| 201601/01/2016 – 31/12/2016 | - | -118K | 68K | -575K | - | |
| 201501/01/2015 – 31/12/2015 | - | -127K | 62K | -457K | - | |
| 201401/01/2014 – 31/12/2014 | - | -384K | 54K | -330K | - |
Compared to 129 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorThe CVR number of STELLARIS PHARMACEUTICALS ApS is 34708215.
STELLARIS PHARMACEUTICALS ApS is owned by Ranoda Holding ApS.
The management of STELLARIS PHARMACEUTICALS ApS consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager.
In 2025, STELLARIS PHARMACEUTICALS ApS reported a gross profit of DKK -475,262.
STELLARIS PHARMACEUTICALS ApS had 1 employee in 2026 according to the Danish CVR register.
STELLARIS PHARMACEUTICALS ApS was founded on 21 September 2012.
Claim this page to add your logo and social links. Free to get started.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2025. Gross profit came to DKK -475,262, and the net result was DKK -594,882.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2024. Gross profit came to DKK -336,355, and the net result was DKK -486,941.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2023. Gross profit came to DKK -255,845, and the net result was DKK -803,430.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2022. Gross profit came to DKK -162,405, and the net result was DKK -785,988.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2021. Gross profit came to DKK -101,607, and the net result was DKK -538,906.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2020. Gross profit came to DKK -100,936, and the net result was DKK -78,835.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK -70,772, and the net result was DKK -57,616.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2018. Gross profit came to DKK -70,497, and the net result was DKK -112,692.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK -45,200, and the net result was DKK -78,398.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2016. The net result was DKK -117,646.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2015. The net result was DKK -127,288.
As of February 16, 2016, Ranoda Holding ApS is registered as an owner of STELLARIS PHARMACEUTICALS ApS with an ownership share of 100%.
As of February 11, 2016, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of STELLARIS PHARMACEUTICALS ApS.
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2014. The net result was DKK -384,376.
STELLARIS PHARMACEUTICALS ApS has published its interim report for the period September 21, 2012 to December 31, 2013.
As of August 1, 2013, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of STELLARIS PHARMACEUTICALS ApS.
As of August 1, 2013, JUT NR. 2124 ApS has stepped down as auditor of STELLARIS PHARMACEUTICALS ApS.
As of September 21, 2012, JUT NR. 2124 ApS has been appointed auditor of STELLARIS PHARMACEUTICALS ApS.
As of September 21, 2012, Birgit Ter-Borch Gram Lilienfeldt Schjoldager is registered as director of STELLARIS PHARMACEUTICALS ApS.
STELLARIS PHARMACEUTICALS ApS was founded on September 21, 2012.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 45663205
CVR 36980222
CVR 42790516
CVR 45430324
CVR 43134477
